Cargando…

An In Vitro Microneutralization Assay for Influenza Virus Serology

Influenza is an infectious respiratory disease with significant morbidity and mortality rates among people of all ages. Influenza viruses spread and evolve rapidly in the human population. Different immune histories, given by previous exposures to influenza virus infections and/or vaccinations, resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuevas, Frans, Kawabata, Hisaaki, Krammer, Florian, Carreño, Juan Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298957/ https://www.ncbi.nlm.nih.gov/pubmed/35848945 http://dx.doi.org/10.1002/cpz1.465

Ejemplares similares

A rapid and flexible microneutralization assay for serological assessment of influenza viruses
por: Rumfelt, Kalee E., et al.
Publicado: (2023)

SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
por: Souiri, Amal, et al.
Publicado: (2023)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays
por: Heeringa, Marten, et al.
Publicado: (2020)

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study
por: Waldock, Joanna, et al.
Publicado: (2023)

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
por: Camacho-Lovillo, M. S., et al.
Publicado: (2017)

Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay
por: Shambaugh, Cindy, et al.
Publicado: (2017)

Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Novel microneutralization assay for HCMV using automated data collection and analysis
por: Abai, Anna Maria, et al.
Publicado: (2007)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
por: Kim, Seung Youn, et al.
Publicado: (2012)

Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis
por: Zielinska, Edyta, et al.
Publicado: (2005)

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018)

A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species
por: Bohning, Kelly, et al.
Publicado: (2021)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas
por: Nascimento, Eduardo J. M., et al.
Publicado: (2019)

Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2015)

The use of an in vitro microneutralization assay to evaluate the potential of recombinant VP5 protein as an antigen for vaccinating against Grass carp reovirus
por: He, Yongxing, et al.
Publicado: (2011)

Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children
por: Verschoor, Chris P., et al.
Publicado: (2016)

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
por: Stadlbauer, Daniel, et al.
Publicado: (2020)

Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore
por: Hsu, Jung Pu, et al.
Publicado: (2014)

SARS-CoV-2 Multi-Antigen Serology Assay
por: Mazhari, Ramin, et al.
Publicado: (2021)

Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice
por: Strohmeier, Shirin, et al.
Publicado: (2021)

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
por: Laurie, Karen L., et al.
Publicado: (2015)

Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi- Species Validation and Evaluation in a Human Diagnostic Cohort
por: Hoornweg, Tabitha E., et al.
Publicado: (2020)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

Commentary: Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi-Species Validation and Evaluation in a Human Diagnostic Cohort
por: Clement, Jan, et al.
Publicado: (2021)

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
por: Stephenson, Iain, et al.
Publicado: (2009)

The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1)
por: TAVAKOLI, Ahmad, et al.
Publicado: (2017)

High-throughput viral microneutralization method for feline coronavirus using image cytometry
por: Pearson, Morgan, et al.
Publicado: (2020)

A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients
por: Goh, Yun Shan, et al.
Publicado: (2021)

Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms
por: Carreño, Juan Manuel, et al.
Publicado: (2021)

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America
por: Carpp, Lindsay N., et al.
Publicado: (2020)

Comparative Serological Assays for the Study of H5 and H7 Avian Influenza Viruses
por: Molesti, Eleonora, et al.
Publicado: (2013)

Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)

A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum
por: Abidi, Syed Hani, et al.
Publicado: (2021)

SEROLOGICAL STUDIES OF SWINE INFLUENZA VIRUSES
por: Shope, Richard E.
Publicado: (1939)

Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017
por: Zhu, Houshun, et al.
Publicado: (2018)

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2022)

Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents
por: Wang, Biao, et al.
Publicado: (2017)

Comparison of serological assays for detecting antibodies in ducks exposed to H5 subtype avian influenza virus
por: Wibawa, Hendra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cs66l6o2f96rors5kdl5o45p4d